Clinical validation of quantitative SARS-CoV-2 antigen assays to estimate SARS-CoV-2 viral loads in nasopharyngeal swabs

BACKGROUND: Expansion of the testing capacity for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an important issue to mitigate the pandemic of coronavirus disease-2019 (COVID-19) caused by this virus. Recently, a sensitive quantitative antigen test (SQT), Lumipulse® SARS-CoV-2 Ag,...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoki, Kotaro, Nagasawa, Tatsuya, Ishii, Yoshikazu, Yagi, Shintaro, Okuma, Sadatsugu, Kashiwagi, Katsuhito, Maeda, Tadashi, Miyazaki, Taito, Yoshizawa, Sadako, Tateda, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713570/
https://www.ncbi.nlm.nih.gov/pubmed/33423918
http://dx.doi.org/10.1016/j.jiac.2020.11.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713570/
https://www.ncbi.nlm.nih.gov/pubmed/33423918
http://dx.doi.org/10.1016/j.jiac.2020.11.021

Ejemplares similares